This week on Contemporary OB/GYN: Oct 24 to Oct 27
What's coming to Contemporary OB/GYN® this week?
Pregnancy-related homicides a public health priority to reduce maternal mortality rates
Women in the US are more likely to be murdered during pregnancy or soon after childbirth than to die from the country’s top 3 leading causes of maternal death—high blood pressure disorders, hemorrhage, or sepsis—according to research in The BMJ.
On-demand course available from AUGS: Fundamentals of urogynecology
If you missed the Fundamentals of Urogynecology course this month and are interested in earning Continuing Medical Education (CME) credits from this activity, AUGS is offering an on-demand course for purchase.
Abortion restrictions during COVID-19 pandemic
A study in the journal Contraception found that, within the first year of the COVID-19 pandemic in the US, abortion clinics in states with low or medium hostility to abortion were significantly more likely to embrace innovative medication abortion practices such as changing ultrasound requirements, offering telehealth or dispensing medications without a physical exam, compared to abortion clinics in states with high or extreme hostility to abortion.
Abortion-care disruptions exert disproportionate impact
Service disruptions at the start of the COVID-19 pandemic altered and exacerbated geographic disparities in access to abortion care in Louisiana, according to a study published in Contraception.
Read more
Check back soon for additional updates!
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
